KEGG   PATHWAY: ngi04650
Entry
ngi04650                    Pathway                                
Name
Natural killer cell mediated cytotoxicity - Nannospalax galili (Upper Galilee mountains blind mole rat)
Description
Natural killer (NK) cells are lymphocytes of the innate immune system that are involved in early defenses against both allogeneic (nonself) cells and autologous cells undergoing various forms of stress, such as infection with viruses, bacteria, or parasites or malignant transformation. Although NK cells do not express classical antigen receptors of the immunoglobulin gene family, such as the antibodies produced by B cells or the T cell receptor expressed by T cells, they are equipped with various receptors whose engagement allows them to discriminate between target and nontarget cells. Activating receptors bind ligands on the target cell surface and trigger NK cell activation and target cell lysis. However Inhibitory receptors recognize MHC class I molecules (HLA) and inhibit killing by NK cells by overruling the actions of the activating receptors. This inhibitory signal is lost when the target cells do not express MHC class I and perhaps also in cells infected with virus, which might inhibit MHC class I exprssion or alter its conformation. The mechanism of NK cell killing is the same as that used by the cytotoxic T cells generated in an adaptive immune response; cytotoxic granules are released onto the surface of the bound target cell, and the effector proteins they contain penetrate the cell membrane and induce programmed cell death.
Class
Organismal Systems; Immune system
Pathway map
ngi04650  Natural killer cell mediated cytotoxicity
ngi04650

Other DBs
GO: 0042267
Organism
Nannospalax galili (Upper Galilee mountains blind mole rat) [GN:ngi]
Gene
103724452  Tnf; tumor necrosis factor [KO:K03156]
103724461  Ncr3; natural cytotoxicity triggering receptor 3 [KO:K06743]
103724895  Ifngr1; interferon gamma receptor 1 [KO:K05132]
103725694  [KO:K05859] [EC:3.1.4.11]
103726091  [KO:K06856]
103726107  Braf; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]
103726215  Shc3; SHC adaptor protein 3 [KO:K17448]
103726390  Mapk3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
103726413  Lat; linker for activation of T-cells [KO:K07362]
103726419  Itgal; integrin subunit alpha L [KO:K05718]
103726484  Rac1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) [KO:K04392]
103726879  Pik3r2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]
103727492  Ptpn6; protein tyrosine phosphatase, non-receptor type 6 [KO:K05697] [EC:3.1.3.48]
103728037  Ppp3ca; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]
103729666  Prkcg; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]
103729807  [KO:K06541]
103729944  Hcst; hematopoietic cell signal transducer [KO:K07988]
103729945  Tyrobp; TYRO protein tyrosine kinase binding protein [KO:K07992]
103730003  Ptk2b; protein tyrosine kinase 2 beta [KO:K05871] [EC:2.7.10.2]
103730305  Pik3r3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]
103730717  Vav3; vav guanine nucleotide exchange factor 3 [KO:K05730]
103731514  Sos2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]
103731654  [KO:K05414]
103731920  [KO:K07987]
103731921  [KO:K07987]
103731922  [KO:K07987]
103731925  [KO:K07986]
103732523  [KO:K01353] [EC:3.4.21.79]
103732546  [KO:K05414]
103732729  Grb2; growth factor receptor bound protein 2 [KO:K04364]
103733036  Shc4; SHC adaptor protein 4 [KO:K17449]
103733121  Pik3cd; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]
103734750  Ppp3r1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]
103734845  Sh2d1a; SH2 domain containing 1A [KO:K07990]
103734938  Nras; neuroblastoma RAS viral oncogene homolog [KO:K07828]
103735763  Nfatc2; nuclear factor of activated T-cells 2 [KO:K17332]
103736148  [KO:K05414]
103736453  Ifngr2; interferon gamma receptor 2 [KO:K05133]
103736454  [KO:K05130]
103736458  Ifnar2; interferon alpha and beta receptor subunit 2 [KO:K05131]
103736717  Kras; KRAS proto-oncogene, GTPase [KO:K07827]
103736801  Map2k1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
103736944  Ppp3cb; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]
103736978  Prf1; perforin 1 [KO:K07818]
103737178  Vav1; vav guanine nucleotide exchange factor 1 [KO:K05730]
103737276  Map2k2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
103737407  Shc2; SHC adaptor protein 2 [KO:K17447]
103738053  Fas; Fas cell surface death receptor [KO:K04390]
103738088  Zap70; tyrosine-protein kinase ZAP-70 [KO:K07360] [EC:2.7.10.2]
103738596  Pik3ca; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]
103738715  Pik3r1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]
103739490  [KO:K01353] [EC:3.4.21.79]
103739879  Tnfsf10; tumor necrosis factor superfamily member 10 [KO:K04721]
103739902  Cd247; CD247 molecule [KO:K06453]
103739950  Itgb2; integrin subunit beta 2 [KO:K06464]
103740216  Cd48; CD48 molecule [KO:K06479]
103740694  Faslg; Fas ligand [KO:K04389]
103741145  Sh3bp2; SH3 domain binding protein 2 [KO:K07984]
103741442  Mapk1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
103741627  Araf; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]
103742202  Prkca; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]
103742820  Vav2; vav guanine nucleotide exchange factor 2 [KO:K05730]
103742946  Pik3cb; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]
103743005  Pak1; p21 (RAC1) activated kinase 1 [KO:K04409] [EC:2.7.11.1]
103743944  Sos1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]
103743951  Ifnb1; interferon beta 1 [KO:K05415]
103744106  [KO:K01353] [EC:3.4.21.79]
103744668  [KO:K02187] [EC:3.4.22.56]
103744744  Icam2; intercellular adhesion molecule 2 [KO:K06523]
103745085  Ifng; interferon gamma [KO:K04687]
103745151  [KO:K05730]
103745419  Syk; spleen associated tyrosine kinase [KO:K05855] [EC:2.7.10.2]
103745559  Ptpn11; protein tyrosine phosphatase, non-receptor type 11 [KO:K07293] [EC:3.1.3.48]
103745898  Bid; BH3 interacting domain death agonist [KO:K04726]
103745927  Lck; LCK proto-oncogene, Src family tyrosine kinase [KO:K05856] [EC:2.7.10.2]
103745950  Fcer1g; Fc fragment of IgE receptor Ig [KO:K07983]
103745971  Cd244; CD244 molecule [KO:K06582]
103746144  [KO:K05415]
103746653  [KO:K05414]
103746654  [KO:K05414]
103746771  [KO:K06463]
103746784  Sh2d1b; SH2 domain containing 1B [KO:K07989]
103746928  Prkcb; protein kinase C beta [KO:K19662] [EC:2.7.11.13]
103747042  Csf2; colony stimulating factor 2 [KO:K05427]
103747244  Plcg1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]
103747569  Icam1; intercellular adhesion molecule 1 [KO:K06490]
103747869  Ppp3cc; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]
103748128  Nfatc1; nuclear factor of activated T-cells 1 [KO:K04446]
103748176  Lcp2; lymphocyte cytosolic protein 2 [KO:K07361]
103748491  Lat2; linker for activation of T-cells family member 2 [KO:K26356]
103748617  Rac2; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) [KO:K07860]
103748739  [KO:K05859] [EC:3.1.4.11]
103749104  Ppp3r2; calcineurin subunit B type 2 [KO:K06268]
103749533  Fyn; FYN proto-oncogene, Src family tyrosine kinase [KO:K05703] [EC:2.7.10.2]
103750475  Casp3; caspase 3 [KO:K02187] [EC:3.4.22.56]
103751075  Hras; HRas proto-oncogene, GTPase [KO:K02833]
103751171  [KO:K01353] [EC:3.4.21.79]
103751254  Shc1; SHC adaptor protein 1 [KO:K06279]
103751450  Raf1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]
103751925  [KO:K06856]
108490685  [KO:K07987]
108491686  [KO:K04722]
Compound
C00076  Calcium cation
C00165  Diacylglycerol
C01245  D-myo-Inositol 1,4,5-trisphosphate
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Chiesa S, Tomasello E, Vivier E, Vely F.
  Title
Coordination of activating and inhibitory signals in natural killer cells.
  Journal
Mol Immunol 42:477-84 (2005)
DOI:10.1016/j.molimm.2004.07.030
Reference
  Authors
Maghazachi AA.
  Title
Insights into seven and single transmembrane-spanning domain receptors and their signaling pathways in human natural killer cells.
  Journal
Pharmacol Rev 57:339-57 (2005)
DOI:10.1124/pr.57.3.5
Reference
  Authors
Vivier E, Nunes JA, Vely F.
  Title
Natural killer cell signaling pathways.
  Journal
Science 306:1517-9 (2004)
DOI:10.1126/science.1103478
Reference
  Authors
Colucci F, Di Santo JP, Leibson PJ.
  Title
Natural killer cell activation in mice and men: different triggers for similar weapons?
  Journal
Nat Immunol 3:807-13 (2002)
DOI:10.1038/ni0902-807
Reference
  Authors
Perussia B.
  Title
Signaling for cytotoxicity.
  Journal
Nat Immunol 1:372-4 (2000)
DOI:10.1038/80808
Reference
  Authors
Smyth MJ, Cretney E, Kelly JM, Westwood JA, Street SE, Yagita H, Takeda K, van Dommelen SL, Degli-Esposti MA, Hayakawa Y.
  Title
Activation of NK cell cytotoxicity.
  Journal
Mol Immunol 42:501-10 (2005)
DOI:10.1016/j.molimm.2004.07.034
Reference
  Authors
Djeu JY, Jiang K, Wei S.
  Title
A view to a kill: signals triggering cytotoxicity.
  Journal
Clin Cancer Res 8:636-40 (2002)
Reference
  Authors
Smyth MJ, Takeda K, Hayakawa Y, Peschon JJ, van den Brink MR, Yagita H.
  Title
Nature's TRAIL--on a path to cancer immunotherapy.
  Journal
Immunity 18:1-6 (2003)
DOI:10.1016/S1074-7613(02)00502-2
Reference
  Authors
Colonna M.
  Title
Fine-tuning NK cell responses: it's a family affair.
  Journal
Nat Immunol 6:961-2 (2005)
DOI:10.1038/ni1005-961
Reference
PMID:8942070
  Authors
Bonnema JD, Leibson PJ.
  Title
Signal transduction during NK cell activation.
  Journal
Chem Immunol 64:28-43 (1996)
Reference
  Authors
Tassi I, Presti R, Kim S, Yokoyama WM, Gilfillan S, Colonna M.
  Title
Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors.
  Journal
J Immunol 175:749-54 (2005)
DOI:10.4049/jimmunol.175.2.749
Reference
PMID:9143705
  Authors
Rao A, Luo C, Hogan PG.
  Title
Transcription factors of the NFAT family: regulation and function.
  Journal
Annu Rev Immunol 15:707-47 (1997)
DOI:10.1146/annurev.immunol.15.1.707
Reference
  Authors
Wu J, Lanier LL.
  Title
Natural killer cells and cancer.
  Journal
Adv Cancer Res 90:127-56 (2003)
DOI:10.1016/S0065-230X(03)90004-2
Reference
  Authors
Cerwenka A, Lanier LL.
  Title
Natural killer cells, viruses and cancer.
  Journal
Nat Rev Immunol 1:41-9 (2001)
DOI:10.1038/35095564
Reference
  Authors
Blott EJ, Griffiths GM.
  Title
Secretory lysosomes.
  Journal
Nat Rev Mol Cell Biol 3:122-31 (2002)
DOI:10.1038/nrm732
Reference
  Authors
Lieberman J.
  Title
The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal.
  Journal
Nat Rev Immunol 3:361-70 (2003)
DOI:10.1038/nri1083
Reference
  Authors
Lord SJ, Rajotte RV, Korbutt GS, Bleackley RC.
  Title
Granzyme B: a natural born killer.
  Journal
Immunol Rev 193:31-8 (2003)
DOI:10.1034/j.1600-065X.2003.00044.x
Reference
  Authors
Liu D, Xu L, Yang F, Li D, Gong F, Xu T.
  Title
Rapid biogenesis and sensitization of secretory lysosomes in NK cells mediated by target-cell recognition.
  Journal
Proc Natl Acad Sci U S A 102:123-7 (2005)
DOI:10.1073/pnas.0405737102
Reference
PMID:9862693
  Authors
Trotta R, Puorro KA, Paroli M, Azzoni L, Abebe B, Eisenlohr LC, Perussia B.
  Title
Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-regulated kinases.
  Journal
J Immunol 161:6648-56 (1998)
Reference
  Authors
Jevremovic D, Billadeau DD, Schoon RA, Dick CJ, Leibson PJ.
  Title
Regulation of NK cell-mediated cytotoxicity by the adaptor protein 3BP2.
  Journal
J Immunol 166:7219-28 (2001)
DOI:10.4049/jimmunol.166.12.7219
Related
pathway
ngi04010  MAPK signaling pathway
ngi04020  Calcium signaling pathway
ngi04060  Cytokine-cytokine receptor interaction
ngi04210  Apoptosis
ngi04630  JAK-STAT signaling pathway
KO pathway
ko04650   

DBGET integrated database retrieval system